wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q30358639-F714B41C-13A8-4044-B0F3-BEECD8DB16D4
Q30358639-F714B41C-13A8-4044-B0F3-BEECD8DB16D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30358639-F714B41C-13A8-4044-B0F3-BEECD8DB16D4
Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.
P2860
Q30358639-F714B41C-13A8-4044-B0F3-BEECD8DB16D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30358639-F714B41C-13A8-4044-B0F3-BEECD8DB16D4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0651dd38d2619b517e7000d1577e6a50bfd4a644
P2860
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.